Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/8242
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOzturk, I. I.en
dc.contributor.authorKourkoumelis, N.en
dc.contributor.authorHadjikakou, S. K.en
dc.contributor.authorManos, M. J.en
dc.contributor.authorTasiopoulos, A. J.en
dc.contributor.authorButler, I. S.en
dc.contributor.authorBalzarini, J.en
dc.contributor.authorHadjiliadis, N.en
dc.date.accessioned2015-11-24T16:40:11Z-
dc.date.available2015-11-24T16:40:11Z-
dc.identifier.issn0095-8972-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/8242-
dc.rightsDefault Licence-
dc.subjectbioinorganic chemistryen
dc.subjectantimony(iii) chloride complexesen
dc.subjectthioamidesen
dc.subjectcrystal structureen
dc.subjectcytotoxic activityen
dc.subjectcrystal-structureen
dc.subjectin-vitroen
dc.subjectdiphenylantimony(iii) derivativesen
dc.subjectstructural-characterizationen
dc.subjectmolecular-structureen
dc.subjectx-rayen
dc.subjectcomplexesen
dc.subjectspectroscopyen
dc.subjectthioamidesen
dc.subjectdensityen
dc.titleInteraction of antimony(III) chloride with thiourea, 2-mercapto-5-methyl-benzimidazole, 3-methyl-2-mercaptobenzothiazole, 2-mercaptopyrimidine, and 2-mercaptopyridineen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primaryDoi 10.1080/00958972.2011.633603-
heal.identifier.secondary<Go to ISI>://000299471200002-
heal.identifier.secondaryhttp://www.tandfonline.com/doi/pdf/10.1080/00958972.2011.633603-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείαςel
heal.publicationDate2011-
heal.abstractNew antimony(III) chloride complexes with heterocyclic thioamides, thiourea (TU), 2-mercapto-5-methyl-benzimidazole (MMBZIM), 3-methyl-2-mercaptobenzothiazole (MMBZT), 2-mercaptopyrimidine (PMT), 2-mercaptopyridine (PYT) of formulae [SbCl3(TU)(2)] (1), [SbCl3(MMBZIM)(2)] (2), [SbCl3(MMBZT)(2)] (3), [SbCl3(PMT)(2)] (4), [SbCl3(mu(2)-S)(PYT)(2)] (5) were synthesized and characterized by elemental analysis, FT-IR and FT-Raman spectroscopies, and TG-DTA analysis. The crystal structure of 5 was also determined by X-ray diffraction. [C10H10Cl3N2S2Sb] (5) crystallizes in space group C2/c, with a = 25.0169(10) angstrom, b = 9.7952(3) angstrom, c = 12.9329(5) angstrom, beta = 109.702(4)degrees, and Z = 8. Crystals of 5 grown from acetonitrile solutions adopt a square-pyramidal geometry. The equatorial plane is formed by three chlorides and one sulfur atom from the thione ligand while the second sulfur is axial. The complexes were evaluated for their biological activities and compared with [SbCl3(MMI)(2)] (6) (MMI = 2-mercapto-1-methylimidazole) and other isostructural ones. The complexes showed moderate cytostatic activity against murine leukemia cells (L1210), murine mammary carcinoma cells (FM3A), human T-lymphocyte (Molt4/C8, CEM), and human cervix carcinoma (HeLa) cells. The chloro and iodo derivatives show better cytostatic activity than the bromo ones.en
heal.publisherElsevieren
heal.journalNameJournal of Coordination Chemistryen
heal.journalTypepeer reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Ozturk-2011-Interaction of antim.pdf604.81 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons